Effectiveness of a Standardized Healthcare Education Program in People With Heart Failure
Heart failure is a chronic illness with a high prevalence and impact on the quality of life of the people who experience it, associated with high hospital taxes and mortality. Beyond the results of traditional clinics, factors such as health literacy, therapeutic adherence and self-healing play a key role in the evolution of this pathology. Various studies show that inadequate health literacy levels lead to better control of malaria, more re-entry and a lower quality of life.
The objective of this research is to evaluate the effectiveness of a standard health education care program, led by nurses specialized in heart failure, initiating discharge from hospitals and with structured follow-up during the first few months afterward, compared to conventional care. It is intended to analyze its impact on health literacy, therapeutic adherence, self-healing, and quality of life, as well as explore the associated social determinants.
It will last a random clinical trial between two groups (intervention and control) at the Heart Failure Unit of the Figueres Hospital. The participants will be adults admitted for decompensation of heart failure and will be followed for 12 months, with evaluations at admission, at 6 months and at any time after discharge. It is important to serve validated instruments to measure quality of life, health literacy and therapeutic adherence.
It is hoped that the intervention will improve the quality of life and health literacy of people with heart failure, contributing to more equitable care, centered on the person and oriented towards better health outcomes.
Panoramica dello studio
Stato
Stato
Condizioni
Condizioni
Intervento / Trattamento
Intervento / Trattamento
Tipo di studio
Tipo di studio
Iscrizione (Stimato)
Iscrizione
Fase
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
Contatto studio
- Nome: Clara Vargas Farber, RN Nurse
- Numero di telefono: +34972592005
- Email: cvargas@salutemporda.cat
Backup dei contatti dello studio
- Nome: Silvia Zuheros Santó, Administrative
- Email: szuheros@salutemporda.cat
Criteri di partecipazione
Criteri di ammissibilità
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- People who are admitted for decompensated heart failure, and who are going to undergo post-discharge monitoring at the Heart Failure Unit of the Figueres Hospital.
- have signed the informed consent.
Exclusion Criteria:
- People diagnosed with cognitive impairment or dementia.
- Institutionalized people.
- Foreign people or people who live outside the hospital's reference area.
- People with language difficulties.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Prevenzione
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Numero di armi
Armi e interventi
Gruppo di partecipanti / ArmGruppo di partecipanti / Arm |
Intervento / TrattamentoIntervento / Trattamento |
|---|---|
|
Sperimentale: Educational group
In the case of the intervention group, a standardized, structured and more intense follow-up plan than usual will be applied. |
This next step will begin after discharge from the hospital with a face-to-face visit from specialized nursing, in which a comprehensive assessment will be carried out, the administration of measurement scales, individualized health education and coordination of primary care and other assistance devices if necessary. |
|
Nessun intervento: control group
usual nursing care |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Number of patients with nursing intervention who need hospital admission in a year
Lasso di tempo: From enrollment to the end of treatment at 12 months
|
Review of the patient's medical history at the annual visit to see how many times they have been admitted for heart failure decompensation. The number of admissions, the main admission diagnosis, and the number of days in the hospital will be reviewed |
From enrollment to the end of treatment at 12 months
|
|
Number of visits to the emergency room in the past year for patients who have undergone the nursing intervention
Lasso di tempo: From enrollment to the end of treatment at 12 months
|
Review of the patient's medical history at the annual visit to see the number of emergency visits for heart failure decompensation. The number of visits to the emergency room, the reason for the visit, the main diagnosis at discharge, and the patient's destination will be checked |
From enrollment to the end of treatment at 12 months
|
Misure di risultato secondarie
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Number of people with a good level of self-care according to the scale Self-Care of Heart Failure Index who have received intervention from the nurse
Lasso di tempo: From enrollment to the end of treatment at 12 months
|
The questionnaire consists of 22 items spread across three independent scales that assess the patient's behaviors over the past month. The items are answered using a four-point Likert scale. The scores for each scale are calculated separately and converted into standardized values from 0 to 100, where higher scores indicate a better level of self-care. A score of 70 or above is considered indicative of adequate self-care. |
From enrollment to the end of treatment at 12 months
|
Collaboratori e investigatori
Sponsor
Sponsor
Investigatori
Investigatori
- Direttore dello studio: Maria Rosa Suñer Soler, RN, PhD, Universitat de Girona
- Cattedra di studio: Aurora Fontova Almató, RN, PhD, Fundacio Salut Emporda
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Inizio studio
Completamento primario (Stimato)
Completamento primario
Completamento dello studio (Stimato)
Completamento dello studio
Date di iscrizione allo studio
Primo inviato
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Primo Inserito
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento pubblicato
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
Altri numeri di identificazione dello studio
- 2026.145
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
It is a single-center study that does not intend to share information with third parties and will only publish the research results.
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .